Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ALKS

Alkermes plc.

CIK 0001520262 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$48.33
↑ 0.31 (0.65%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Ownership, Options

Key stats

Market Cap
$8.11B
P/E Ratio
122.62
EPS
1.47
Dividend Yield
Not covered
52W Position
76%
Beta
0.77

Valuation multiples

Fwd P/E
133.33
PEG
1.96
P/B
4.48
P/S
4.86
EV/Revenue
5.46
ROE
3.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 76%
$25.16$55.67

Latest Financials

2025-12-31 FY
Revenue
$1.48B
Net Income
$241.66M
Total Assets
$2.49B
Free Cash Flow
$480.33M

Recent news